Ophthalmology & Optometry Billing Services

Eye Care Billing: Two Code Sets, High-Dollar Drugs, and Tight Edits

Ophthalmology and optometry billing has a complexity no other specialty shares: two entirely different code sets can describe the same encounter, and the choice between them affects both payment and audit exposure. Layer on high-dollar injectable drugs billed by the microgram, diagnostic tests fenced in by frequency edits, a surgical global system, and a service (refraction) that most medical plans simply don't cover, and eye care becomes one of the most detail-sensitive billing environments in medicine. Small, repeated errors here add up fast.

Eye Codes vs E/M Codes: The Defining Decision

The same office visit can be billed with Eye codes (92002–92014) or with office/outpatient E/M codes (99202–99215), and neither is universally "right." Eye codes describe an ophthalmological examination; E/M codes are leveled on medical decision making or time. The correct choice depends on the chief complaint, what the documentation supports, the payer's policy, and which set pays appropriately for the work performed. Practices that default to one set out of habit routinely leave money on the table or expose themselves on audit. We make the call per encounter, against payer rules — which is where a generic billing service quietly loses eye-care revenue.

Intravitreal Injections and J-Code Drug Billing

Retina practices live on intravitreal injections — and the money is in the drug. The injection procedure (67028) is billed separately from the anti-VEGF agent, which is reported with its own HCPCS J-code and precise units for agents such as aflibercept, ranibizumab, or bevacizumab. These are among the highest-dollar line items in outpatient medicine, which makes them the most costly to get wrong: incorrect units, a missing J-code, or a wasted-drug (JW) modifier omission turns into a large denial or a compliance flag. Nearly all require prior authorization, and a mismatch between the auth and the billed drug produces CO-197. We bill the drug as carefully as the procedure, because per claim it dwarfs it.

Diagnostic Testing, Laterality, and Frequency Edits

OCT (92133/92134), visual fields (92083), fundus photography (92250), and other tests carry payer frequency limits and medical-necessity requirements — bill one too often or against an unsupported diagnosis and it denies as CO-50 or CO-167. Eye care is also intensely laterality-driven, so the correct RT/LT modifiers matter on nearly every test and procedure. We bill to the documented indication, apply laterality correctly, and track frequency edits by payer so testing revenue survives.

Surgery Globals and the Refraction Rule

Cataract surgery (66984) and laser procedures carry global periods with post-op visits, second-eye sequencing, and surgical modifiers that all have to be handled correctly. And then there's refraction (92015): Medicare and most medical plans consider it non-covered, so it's the patient's responsibility (or a vision plan's) — not a write-off. Billing refraction as though it were covered produces reflexive denials and lost revenue; the right handling is to route it to patient or vision-plan responsibility from the start (a proper CO-204 vs PR-204 determination). Getting the covered-versus-non-covered line right on every eye visit is a quiet but real part of an eye practice's margin, and we track the denial rate so nothing slips.